Tag Archives: Randy Vogenberg

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Global Issues Driving US Healthcare Trends in 2021 and 2022

For the remainder of 2021 through the end of 2022, the key trends explored here will reflect the transition from pre-to post–COVID-19 healthcare environment and the related health reengineering by key stakeholders, global influences on domestic decision-making, as well as the effects of evolving federal or state government policies.

Thoughts Around COVID-19: Linking Business & Healthcare

HR leaders need to coordinate on their P&Ps, best practices while collaborating with other executives around managing all risks. Vendors and healthcare supply chains serving the workplace need more collaboration as part of managing all risks related to this pandemic event.

Key Trends in Healthcare for 2020 and Beyond

Transparency has been elevated as consumerism marches forward in the face of steadily increasing healthcare costs

Insights Into Managing Health Benefits In This Era of Change

The healthcare marketplace is undergoing fast-paced changes fueled by political and regulatory events, medical, pharmaceutical and technology advancements, consumerism, and growing payer engagement in value-based reimbursement and contracting.

PBM P&T Practices The HEAT Initiative Is Gaining Momentum

Care outside the hospital, like P&T committee responsibilities outside the hospital, is necessarily different. New processes and solutions, such as cloud computing, can help improve performance and transparency of benefit management for purchasers or users of health care services. The current role of PBMs includes concurrent improvement in health outcomes, so the take-home message is […]

Employer Perspectives Specialty Drug Step-Therapy Program Evaluation

Employer Perspectives Specialty Drug Step-Therapy Program Evaluation American Health and Drug Benefits, September 2016 Vol 9, No 6 – Industry Trends Matthew Harman, PharmD, MPH, Director, Clinical Pharmacy Strategies Employers Health, Columbus, OH F. Randy Vogenberg, PhD, RPh, Strategic Advisor and Co–Project Leader, Midwest Business Group on Health National Employer Biologics & Specialty Drug Initiative […]